RDY
Dr. Reddy'S Laboratories·NYSE
--
--(--)
--
--(--)
3.94 / 10
Netural
Analyst sentiment is limited: one Strong Buy from HSBC, but historical win‑rate is 0% and price has fallen 4.06%. Conversely, fund‑flow scores 7.89/10 with positive inflows across all block sizes, indicating strong buying pressure despite weak analyst backing.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-06-05
InstitutionHSBC
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for RDY?
- RDY holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.94/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
